中文名：Pal-Gly-Gln-Pro-Arg-OH游離態(tài)
英文名：Pal-Gly-Gln-Pro-Arg-OH
英文別名：Pal-Gly-Gln-Pro-Arg-OH|Palmitoyl tetrapeptide-7|221227-05-0|Palmitoyl Tetrapeptide-3|N-Palmitoylrigin|Palmitoyl-GQPR|Q41S464P1R|(2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[2-(hexadecanoylamino)acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomet
純度：≥98.0%
貨號：P292761
包裝：100mg、250mg
Cas號：221227-05-0
存儲溫度：2-8°C儲存
產(chǎn)品介紹：
It can delay and inhibit the production of excessive cell interleukin, thereby? ?inhibiting some unnecessary and inappropriate inflammation and glycosylation damage.
Efficacy and Mechanism of Action
Palmitoyl tetrapeptide-7 (Rigin TM) (sequence: Pal-Gly-Gln-Pro-Arg or pal-GQPR) is a fragment of immunoglobulin G. Palmitoyl tetrapeptide-7 reduces IL-6 secretion in the basic environment and is used as an anti-inflammatory agent after exposure to UVB radiation. In vivo reflection confocal microscopy showed that the mixture of palmitoyl oligopeptide and palmitoyl tetrapeptide-7 enhanced the structure of extracellular matrix compared with placebo.
查看阿拉丁官網(wǎng)此產(chǎn)品相關(guān)對應(yīng)頁面：https://www.aladdin-e.com/zh_cn/P292761.html
關(guān)鍵字： Pal-Gly-Gln-Pro-Arg-OH;Palmitoyl tetrapeptide-7;221227-05-0;Palmitoyl Tetrapeptide-3
上海阿拉丁生化科技股份有限公司是A股上市公司（（股票代碼：688179），專注于科研試劑的研發(fā)、生產(chǎn)和銷售，已陸續(xù)建立多個工廠和研發(fā)中心。作為領(lǐng)軍企業(yè)，阿拉丁始終堅持質(zhì)量第一，連續(xù)13年被評為“最受歡迎試劑品牌”。
阿拉丁目前常備庫存試劑產(chǎn)品品種超過7萬種，SKU總數(shù)超過46萬，產(chǎn)品線涵蓋了化學(xué)試劑、生化試劑、藥靶配體、蛋白質(zhì)和抗體等多個領(lǐng)域，是國內(nèi)少數(shù)化學(xué)試劑到生物試劑全面發(fā)展的國產(chǎn)試劑品牌，產(chǎn)品同步發(fā)布在我們國內(nèi)外電商平臺。